familymednews.com
A clinical trial that followed more than 9,900 people in 24 countries has found that the drug dulaglutide reduced cardiovascular events and kidney problems in middle-aged and older people with Type 2 diabetes. During more than five years of follow-up, cardiovascular events like heart attacks and strokes were reduced by 12% in people taking dulaglutide compared to people taking a […]
Continue reading »
Johns Hopkins Medicine researchers report that a program designed to enhance self-care and lead to more seamless management of chronic obstructive pulmonary disease (COPD) in adults successfully reduced rates of emergency room visits and hospitalization, and the burdensome symptoms and limitations caused by the condition. Describing results of the six-month trial of the program in the Nov. 12 issue of […]
Continue reading »
Recent trends show that primary reason for the measles outbreak affecting several European countries is the decline in vaccination coverage. The spread of anti-scientific theories has been blamed, but it’s not the only reason. A new study conducted by Bocconi scholars Veronica Toffolutti, Alessia Melegaro and David Stuckler, with Martin McKee (London School of Hygiene and Tropical Medicine) and Walter […]
Continue reading »
(HealthDay)—A culturally specific, empowerment-based, and group-delivered behavioral prevention intervention can reduce sexual risk for HIV acquisition and transmission in sexually active young transgender women (YTW), according to a study published online Aug. 13 in JAMA Pediatrics. Robert Garofalo, M.D., M.P.H., from the Ann & Robert H. Lurie Children’s Hospital in Chicago, and colleagues conducted a randomized efficacy trial of a […]
Continue reading »
(HealthDay)—An intervention targeting depression in very young children can be effective in community settings, according to a study published online June 20 in The American Journal of Psychiatry. Joan L. Luby, M.D., from Washington University in St. Louis, and colleagues conducted a randomized controlled trial of psychotherapy (parent-child interaction therapy with a novel “emotion development” module [PCIT-ED]) for early childhood […]
Continue reading »
(HealthDay)—Dexmedetomidine prevents excessive γ-aminobutyric acid type A receptor function after anesthesia, according to a study published online June 7 in Anesthesiology. Dian-Shi Wang, M.D., Ph.D., from the University of Toronto, and colleagues studied injectable and inhaled anesthetic drugs (etomidate and sevoflurane) using cultured murine hippocampal neurons, cultured murine and human cortical astrocytes, and ex vivo murine hippocampal slices. Using electrophysiologic […]
Continue reading »
(HealthDay)—An emotion regulation intervention reduced sexual risk behaviors among at-risk middle school students, according to a study published online May 10 in Pediatrics. Christopher D. Houck, Ph.D., from Brown University in Providence, R.I., and colleagues compared an emotion regulation-focused program to a time- and attention-matched comparison group among seventh grade adolescents with suspected mental health symptoms, participating in a six-week, […]
Continue reading »